RAC 3.79% $1.53 race oncology ltd

RAC - Charts & Price Action, page-10593

  1. 959 Posts.
    lightbulb Created with Sketch. 555
    Interesting. So, on that logic, Scneario2 is less likely in the near future. Or, JC simply needed some quick money for whatever reasons.
    Do you know, if we are waiting for any other animal data, before formalizing chats regarding carfilzomib(Amgen, J&J)?
    Licensing/partnership discussions might take more than a few months to eventuate after either party approaches another for discussions.

    @Mason14, speculated previously partnership was likely by June this year.
    Anyways, would be nice to receive this quarter's news first.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.